VirtaMed develops simulators for Femasys
Schlieren/Suwanee - VirtaMed is entering into a partnership with Femasys. U.S.-based Femasys is a biomedical company focusing on women’s healthcare. VirtaMed has produced simulators for Femasys.
L'Oréal acquires 10 percent stake in Galderma
Zug/Clichy - L’Oréal has acquired a stake of 10 percent in Galderma. As such, the French cosmetics company and the Zug-based dermatology specialists are working towards a scientific collaboration to combat skin aging.
Loft Dynamics receives qualification for VR flight simulator in the USA
Dübendorf/Santa Monica - Loft Dynamics has secured US qualification for its flight simulator powered by Virtual Reality (VR) technology. The simulator has also been given the green light by the European Aviation Safety Agency.
LimmaTech and Valneva join forces to combat shigellosis
Schlieren/Saint-Herblain - LimmaTech Biologics and Valneva are working together on the development of a vaccine candidate to treat the diarrheal disease shigellosis. Valneva will receive an exclusive global license for the S4V Shigella vaccine.
Boldbrain Challenge 2024 supports 20 startups
Lugano/Manno - The Boldbrain Startup Challenge has named the 20 startups that will receive support in the seventh edition of the incubator in Manno in the Swiss canton of Ticino. The companies hail from the ICT, medtech, energy and cleantech sectors as well as finance and insurance technology.
Nevis and Swiss Casinos agree to join forces
Zurich - The software development firm Nevis Security and Swiss Casinos have entered into a strategic partnership. The specialist for password-free identification processes will be tasked with securing the gaming universe of Swiss Casinos.
c.technology to provide mobile app for Schwalbe e-scooters
Zurich/Munich - GOVECS is now making use of the expertise of c.technology. With the APIs and cloud-based mobility services from c.technology, the Munich-based manufacturer of the Schwalbe electric scooters in a retro design intends to allow its customers to access a wide range of innovative functions.
Impli and Yalosys develop fertility monitoring implant with CSEM
Root/Hünenberg/Neuenburg - Impli has developed a tiny, implantable biosensor to monitor fertility hormones in real time. It aims to help women on the path to becoming pregnant during assisted reproduction. CSEM and Yalosys are honing the sensor until clinical testing starts in 2025.
Lakera raises 20 million US dollars
Zurich/San Francisco - Lakera AI has received 20 million US dollars in a series A funding round. The startup plans to use this to further develop its real-time security for generative artificial intelligence in companies. Additionally, it aims to significantly expand its locations in the USA and Switzerland.
Meet with an expansion expert
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line.